Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.20 USD
Change Today +0.03 / 2.56%
Volume 289.1K
ENZN On Other Exchanges
As of 7:40 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard C. Mulligan Ph.D.

Former Vice Chairman and Chairman of Governance & Nominating Committee, Enzon Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 5 different industries.

See Board Relationships


Prof. Dr. Richard C. Mulligan, Ph.D. serves as a Consultant of DuPont, Genetics Institute and AMGEN. Prof. Dr. Mulligan is the Founder of Somatix Therapy Corporation and served as its Chief Scientific Officer. He served as Vice Chairman of the Board of Managers of Kadmon Pharmaceuticals LLC. Prof. Dr. Mulligan served as the Vice Chairman of Enzon Pharmaceuticals Inc. from March 17, 2011 to November 20, 2013 and its Director from 2009 to November 20, 2013. He serves as ...

Read Full Background

Corporate Headquarters*

20 Kingsbridge Road
Piscataway, New Jersey 08854

United States

Phone: 732-980-4500
Fax: --

Board Members Memberships*

Former Independent Director
Former Vice Chairman of the Board of Managers
Former Director, Member of Audit Committee, Member of Executive Committee, Member of Nominating & Corporate Governance Committee and Member of Research & Development Oversight Committee
Independent Director, Chairman of Science & Technology Committee and Member of Compensation & Management Development Committee
Former Vice Chairman and Chairman of Governance & Nominating Committee


Massachusetts Institute of Technology
Post-Doctoral Training
Massachusetts Institute of Technology
Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$100,625
Total Calculated Compensation$370,134
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZN:US $1.20 USD +0.03


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at